This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback
Trial record 17 of 68 for:    hypercoagulation OR thrombophilia OR blood clotting | Recruiting, Not yet recruiting, Available Studies | NIH, U.S. Fed

Chronology of Occult and Gross Coagulopathy in Burn Patients

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2016 by Medstar Health Research Institute
United States Department of Defense
Information provided by (Responsible Party):
Medstar Health Research Institute Identifier:
First received: July 9, 2012
Last updated: July 13, 2016
Last verified: July 2016
The purpose of the study is to identify the inflammatory and coagulation pathways and mechanisms that are activated immediately following burn injury, and how they affect outcomes in terms of organ failure and death. This study also addresses the limitation of current tests (PT, PTT, and platelet counts) employed to identify coagulation disturbances in severely injured patients both in a comprehensive and rapid manner.

Thermal Burns

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Determining the Chronology of Occult and Gross Coagulopathy in Thermally Injured Patients: A Systems Biology Approach

Resource links provided by NLM:

Further study details as provided by Medstar Health Research Institute:

Estimated Enrollment: 85
Study Start Date: July 2012
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Group #1 - Burns affecting less than 10% BSA
Group #2 - Burns affecting 10%-30% TBSA
Group #3 - Burns affecting 31%-50% TBSA
Group #4 - Burns affecting 51%-70% TBSA
Group #5 - Burns affecting >70% TBSA


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Burn injury patients will be enrolled in the study upon arrival at Trauma Center.

Inclusion Criteria:

  • Patients, male or female, > or = 18 years of age, who arrive at Burn/Trauma Center with anticipated admission to The Burn Center within 4 hours of injury, with a thermal burn injury due to flash, flame, contact with hot object or liquid.

Exclusion Criteria:

  • Patients suffering concomitant trauma that are in hemorrhagic shock. Patients with a preexisting history of coagulopathy, or currently taking anti-coagulants. Children and pregnant women. Patients with chemical or electrical injury. Patients who do not fluently speak either English or Spanish.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01638481

Contact: Melissa McLawhorn 202-877-6181

United States, District of Columbia
MedStar Washington Hospital Center Recruiting
Washington, District of Columbia, United States, 20010
Principal Investigator: Jeffrey Shupp, MD         
Sponsors and Collaborators
Medstar Health Research Institute
United States Department of Defense
Principal Investigator: Jeffrey Shupp, MD Washington Hospital Center
  More Information

Responsible Party: Medstar Health Research Institute Identifier: NCT01638481     History of Changes
Other Study ID Numbers: 58802-LS
Study First Received: July 9, 2012
Last Updated: July 13, 2016

Additional relevant MeSH terms:
Blood Coagulation Disorders
Hemostatic Disorders
Hematologic Diseases
Vascular Diseases
Cardiovascular Diseases
Hemorrhagic Disorders processed this record on September 21, 2017